Susan Hockfield

Medical & BiotechPosted by
The Associated Press

Susan Hockfield, Ph.D., MIT President Emerita, Joins Repertoire Immune Medicines Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 27, 2021-- Repertoire Immune Medicines, a clinical-stage biotech company decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious disease, and other serious diseases, today announced the company has elected neuroscience researcher and educator, Susan Hockfield, Ph.D., President Emerita of MIT, to its board of directors.
Picture for Susan Hockfield, Ph.D., MIT President Emerita, Joins Repertoire Immune Medicines Board of Directors
RELATED CHANNELS
RELATED PUBLISHERS